Business
Astonea Labs Limited Press Release Nov 28 2025
Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/12/2025 ,inter alia, to consider and approve 1. To consider and approve the Notice convening the Annual General Meeting (AGM) of the Company for the financial year 2024-25.2. To review and approve the Directors' Report for the financial year ended 31.03.2025.3. To approve the appointment of the Company Secretary and Compliance Officer of the Company.4. To acknowledge and accept the resignation of Mr. Pardeep Singh (DIN: 10345015) , Director of the Company.5. To consider and approve the acquisition of equity stake in Damaira Pharmaceuticals Private Limited.6. To consider and approve the relocation/shifting of the Company's corporate office and authorize the Board to complete all formalities in this regard.7. To consider and approve the proposal for voluntary transition from AS to Ind AS.8. To consider and approve the proposal for opening and making investments in multiple foreign subsidiaries/wholly owned subsidiaries.9. To consider and approve the Policy for Preservation of Documents of the Company10-17. Others
About this update from Astonea Labs Limited
Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/12/2025 ,inter alia, to consider and approve 1. To consider and approve the Notice convening the Annual General Meeting (AGM) of the Company for the financial year 2024-25.2. To review and approve the Directors' Report for the financial year ended 31.03.2025.3. To approve the appointment of the Company Secretary and Compliance Officer of the Company.4. To acknowledge and accept the resignation of Mr. Pardeep Singh (DIN: 10345015) , Director of the Company.5. To consider and approve the acquisition of equity stake in Damaira Pharmaceuticals Private Limited.6. To consider and approve the relocation/shifting of the Company's corporate office and authorize the Board to complete all formalities in this regard.7. To consider and approve the proposal for voluntary transition from AS to Ind AS.8. To consider and approve the proposal for opening and making investments in multiple foreign subsidiaries/wholly owned subsidiaries.9. To consider and approve the Policy for Preservation of Documents of the Company10-17. Others View Attachment
View stock analysis, news, and events for Astonea Labs Limited